{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:23:14Z","timestamp":1782307394772,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Ottawa Tier 1 and Tier 2 Research Chair Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Children's Hospital of Eastern Ontario Departments of Pediatrics and Surgery","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Children's Hospital of Eastern Ontario Research Institute","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 64285"],"award-info":[{"award-number":["FRN 64285"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11914-021-00672-0","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T06:02:41Z","timestamp":1624082561000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Part 2: When Should Bisphosphonates Be Used in Children with Chronic Illness Osteoporosis?"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-9185","authenticated-orcid":false,"given":"Leanne M.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"issue":"7","key":"672_CR1","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","volume":"27","author":"LM Ward","year":"2016","unstructured":"Ward LM, Konji VN, Ma J. The management of osteoporosis in children. Osteoporos Int. 2016;27(7):2147\u201379.","journal-title":"Osteoporos Int"},{"issue":"4","key":"672_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11914-017-0371-2","volume":"15","author":"M Grover","year":"2017","unstructured":"Grover M, Bachrach LK. Osteoporosis in children with chronic illnesses: diagnosis, monitoring, and treatment. Curr Osteoporos Rep. 2017;15(4):271\u201382.","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"672_CR3","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2015-2680","volume":"100","author":"S George","year":"2015","unstructured":"George S, Weber DR, Kaplan P, Hummel K, Monk HM, Levine MA. Short-term safety of zoledronic acid in young patients with bone disorders: an extensive institutional experience. J Clin Endocrinol Metab. 2015;100(11):4163\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"672_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bone.2019.01.003","volume":"121","author":"N Nasomyont","year":"2019","unstructured":"Nasomyont N, Hornung LN, Gordon CM, Wasserman H. Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review. Bone. 2019;121:60\u20137.","journal-title":"Bone"},{"key":"672_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fendo.2020.00576","volume":"11","author":"LM Ward","year":"2020","unstructured":"Ward LM. Glucocorticoid-induced osteoporosis: why kids are different. Front Endocrinol (Lausanne). 2020;11:576.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"672_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00198-008-0832-7","volume":"20","author":"S Kerkeni","year":"2009","unstructured":"Kerkeni S, Kolta S, Fechtenbaum J, Roux C. Spinal Deformity Index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int. 2009;20(9):1547\u201352.","journal-title":"Osteoporos Int"},{"issue":"1","key":"672_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1359\/jbmr.1997.12.1.152","volume":"12","author":"H Burger","year":"1997","unstructured":"Burger H, Van Daele PL, Grashuis K, Hofman A, Grobbee DE, Schutte HE, et al. Vertebral deformities and functional impairment in men and women. J Bone Miner Res. 1997;12(1):152\u20137.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"672_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","volume":"128","author":"MC Nevitt","year":"1998","unstructured":"Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998;128(10):793\u2013800.","journal-title":"Ann Intern Med"},{"issue":"2","key":"672_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11914-017-0352-5","volume":"15","author":"Center JR","year":"2017","unstructured":"Center JR. Fracture burden: what two and a half decades of Dubbo Osteoporosis Epidemiology Study data reveal about clinical outcomes of osteoporosis. Curr Osteoporos Rep. 2017;15(2):88\u201395.","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"672_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00198-017-4337-0","volume":"29","author":"R Watanabe","year":"2018","unstructured":"Watanabe R, Shiraki M, Saito M, Okazaki R, Inoue D. Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women. Osteoporos Int. 2018;29(3):625\u201333.","journal-title":"Osteoporos Int"},{"issue":"12","key":"672_CR11","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cgh.2008.07.010","volume":"6","author":"M Thayu","year":"2008","unstructured":"Thayu M, Leonard MB, Hyams JS, Crandall WV, Kugathasan S, Otley AR, et al. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn\u2019s disease: results of the REACH study. Clin Gastroenterol Hepatol. 2008;6(12):1378\u201384.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"672_CR12","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1542\/peds.2004-1838","volume":"116","author":"D Marinovic","year":"2005","unstructured":"Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Pediatrics. 2005;116(1):e102\u20138.","journal-title":"Pediatrics"},{"issue":"7","key":"672_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/pbc.25010","volume":"61","author":"JG Gurney","year":"2014","unstructured":"Gurney JG, Kaste SC, Liu W, Srivastava DK, Chemaitilly W, Ness KK, et al. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2014;61(7):1270\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"672_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1530\/EJE-12-0702","volume":"168","author":"O Makitie","year":"2013","unstructured":"Makitie O, Heikkinen R, Toiviainen-Salo S, Henriksson M, Puukko-Viertomies LR, Jahnukainen K. Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study. Eur J Endocrinol. 2013;168(2):281\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"672_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/jbmr.3589","volume":"34","author":"A Kelly","year":"2019","unstructured":"Kelly A, Shults J, Mostoufi-Moab S, McCormack SE, Stallings VA, Schall JI, et al. Pediatric bone mineral accrual Z-score calculation equations and their application in childhood disease. J Bone Miner Res. 2019;34(1):195\u2013203.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"672_CR16","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1210\/jc.2012-2393","volume":"97","author":"S Mostoufi-Moab","year":"2012","unstructured":"Mostoufi-Moab S, Brodsky J, Isaacoff EJ, Tsampalieros A, Ginsberg JP, Zemel B, et al. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab. 2012;97(10):3584\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"672_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1067\/mpd.2002.125728","volume":"141","author":"IM van der Sluis","year":"2002","unstructured":"van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr. 2002;141(2):204\u201310.","journal-title":"J Pediatr"},{"issue":"8","key":"672_CR18","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jbmr.3447","volume":"33","author":"LM Ward","year":"2018","unstructured":"Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, et al. Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study. J Bone Miner Res. 2018;33(8):1435\u201343.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"672_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jbmr.2756","volume":"31","author":"BM Misof","year":"2016","unstructured":"Misof BM, Roschger P, McMillan HJ, Ma J, Klaushofer K, Rauch F, et al. Histomorphometry and bone matrix mineralization before and after bisphosphonate treatment in boys with Duchenne muscular dystrophy: a paired transiliac biopsy study. J Bone Miner Res. 2016;31(5):1060\u20139.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"672_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00198-009-0969-z","volume":"21","author":"LM Ward","year":"2010","unstructured":"Ward LM, Rauch F, Matzinger MA, Benchimol EI, Boland M, Mack DR. Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporos Int. 2010;21(2):331\u20137.","journal-title":"Osteoporos Int"},{"issue":"11","key":"672_CR21","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00198-012-1911-3","volume":"23","author":"AM Sbrocchi","year":"2012","unstructured":"Sbrocchi AM, Rauch F, Jacob P, McCormick A, McMillan HJ, Matzinger MA, et al. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Osteoporos Int. 2012;23(11):2703\u201311.","journal-title":"Osteoporos Int"},{"issue":"4","key":"672_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347\u201361.","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"672_CR23","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1542\/peds.2018-0333F","volume":"142","author":"DR Weber","year":"2018","unstructured":"Weber DR, Hadjiyannakis S, McMillan HJ, Noritz G, Ward LM. Obesity and endocrine management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Suppl 2):S43\u201352.","journal-title":"Pediatrics"},{"issue":"1","key":"672_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MED.0000000000000456","volume":"26","author":"LM Ward","year":"2019","unstructured":"Ward LM, Weber DR. Growth, pubertal development, and skeletal health in boys with Duchenne muscular dystrophy. Curr Opin Endocrinol Diabetes Obes. 2019;26(1):39\u201348.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"672_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12969-020-0411-9","volume":"18","author":"R Galindo-Zavala","year":"2020","unstructured":"Galindo-Zavala R, Bou-Torrent R, Magallares-Lopez B, Mir-Perello C, Palmou-Fontana N, Sevilla-Perez B, et al. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatr Rheumatol Online J. 2020;18(1):20.","journal-title":"Pediatr Rheumatol Online J"},{"key":"672_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000381045","volume":"28","author":"W Hogler","year":"2015","unstructured":"Hogler W, Ward L. Osteoporosis in children with chronic disease. Endocr Dev. 2015;28:176\u201395.","journal-title":"Endocr Dev"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-021-00672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-021-00672-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-021-00672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T07:35:15Z","timestamp":1627112115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-021-00672-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1007\/s11914-021-00672-0","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"12 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ward has participated in clinical trials with ReveraGen BioPharma, PTC Therapeutics, Catabasis Pharmaceuticals, Novartis, and Amgen. Dr. Ward has also received consulting fees from PTC Therapeutics, Novartis, and Amgen, with funds to the Children\u2019s Hospital of Eastern Ontario Research Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any original studies with human or animal subjects performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}